Global Leader
in Stem Cell Therapeutics

0+

Number of registered patents
in Korea and overseas

0+

Number of national R&D
grants received in Korea

0

Number of private cord blood
units stored

0%

Percentage of
R&D staff

First-Generation Stem Cell Products

CARTISTEM®
Treatment of knee cartilage defects including for patients with Knee Osteoarthritis
PNEUMOSTEM®
Preventive treatment of bronchopulmonary dysplasia(BPD)

Second-Generation Stem Cell Products

SMUP-IA-01
Intra-articular Injectable treatment for osteoarthritis
SMUP-IV-01
Intra-venous infusion treatment for diabetic nephropathy

Global Leader in Stem Cell Therapeutics

As a global leader in biotechnology with cutting-edge Technologies in Stem Cell Therapeutics, MEDIPOST continues to innovate and challenge to tackle unmet medical needs.